Cytek Biosciences, Inc. logo CTKB - Cytek Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 1
SELL 1
STRONG
SELL
0
| PRICE TARGET: $5.13 DETAILS
HIGH: $5.50
LOW: $4.75
MEDIAN: $5.12
CONSENSUS: $5.13
UPSIDE: 27.93%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 44.1 62.1 52.3 45.6 41.5 57.5 51.5 46.6 44.9 58.2 48 49.7 37.1 48.3 40.5 40.2 35.1 38.9 34.4 30.4 24.3 30.6 25.1 19.1 18.0
Cost of Revenue 22.9 29.3 24.7 21.7 21.3 23.8 22.5 21.2 21.8 25.2 20.8 21.5 16.1 19.0 13.6 15.6 14.9 15.3 13.1 10.7 9.8 11.2 9.5 10.9 9.6
Gross Profit 21.3 32.9 27.6 23.9 20.2 33.7 29.0 25.4 23.0 33.0 27.2 28.2 21.0 29.4 26.9 24.6 20.2 23.6 21.3 19.7 14.5 19.4 15.6 8.3 8.4
Operating Expenses
R&D Expenses 9.6 9.0 9.0 8.8 9.7 9.7 9.9 10.0 9.8 10.9 11.2 12.1 10.0 9.7 8.7 8.4 8.0 7.1 6.1 6.2 5.1 4.4 3.4 2.9 3.0
SG&A Expenses 30.1 29.5 27.8 25.7 25.4 20.9 23.4 24.0 24.0 22.3 22.4 25.2 23.2 19.5 16.9 17.0 14.5 15.2 12.3 9.7 8.3 7.2 5.5 5.6 6.1
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 39.7 38.5 36.7 34.5 35.1 30.7 33.3 34.0 33.7 33.2 33.6 37.3 33.2 29.3 25.5 25.5 22.5 22.3 18.4 15.9 13.4 11.6 8.9 8.5 9.1
Operating Income
Operating Income (18.5) (5.6) (9.2) (10.6) (15.0) 3.0 (4.2) (8.5) (10.7) (0.1) (6.4) (9.1) (12.2) 0.1 1.4 (0.9) (2.4) 1.3 2.9 3.8 1.1 7.9 6.7 (0.2) (0.7)
Interest Expense 0.3 0.7 0.5 0.4 0.3 0 0.1 0.1 0.4 0.4 0.6 0.4 0.7 0.7 0.6 0.6 0.6 0.5 0.4 0.4 0.4 0.3 0.0 0.0 0
Interest Income 0.8 0.6 0.6 0.6 0.5 6.2 1.4 1.4 1.4 1.4 1.6 1.2 2.1 2.6 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
Profitability
EBITDA (15.7) (0.3) (4.2) (3.4) (8.1) (2.5) 3.1 (4.6) (6.1) 6.9 (1.0) (4.6) (7.4) 6.7 3.3 0.1 (1.2) 1.6 2.7 3.9 0.7 8.5 7.1 0.4 (0.6)
EBIT (18.5) (3.3) (7.3) (6.4) (11.0) (5.2) 0.3 (7.1) (8.6) 4.5 (3.6) (6.2) (8.4) 4.8 2.5 (0.8) (2.7) 0.9 2.5 3.7 0.5 8.3 6.9 0.2 (0.7)
Income Before Tax (17.4) (4.0) (7.8) (6.8) (11.3) 10.3 0.2 (7.2) (9.0) 4.1 (4.2) (6.6) (9.0) 4.1 1.9 (1.4) (3.3) 0.4 2.1 3.3 0.2 8.0 6.9 0.2 (0.7)
Income Tax Expense 1.5 40.0 (2.3) (1.2) 0.1 0.7 (0.8) 3.2 (2.8) (1.4) 2.3 (2.2) (2.2) 0.4 0.2 (0.7) (1.1) 1.6 0.7 0.6 0.1 2.4 0.4 (7.9) 0.2
Net Income (18.9) (44.1) (5.5) (5.6) (11.4) 9.6 0.9 (10.4) (6.2) 5.5 (6.5) (4.4) (6.8) 3.5 1.7 (0.6) (2.0) (1.2) 1.4 2.7 0.1 5.6 6.5 8.1 (0.8)
Per Share Data
EPS (Basic) -0.15 -0.34 -0.04 -0.04 -0.09 0.07 0.01 -0.08 -0.05 0.04 -0.05 -0.03 -0.05 0.03 0.01 -0.00 -0.02 0.00 0.01 0.02 0.00 0.05 0.05 0.06 -0.01
EPS (Diluted) -0.15 -0.34 -0.04 -0.04 -0.09 0.07 0.01 -0.08 -0.05 0.04 -0.05 -0.03 -0.05 0.03 0.01 -0.00 -0.02 0.00 0.01 0.02 0.00 0.05 0.05 0.06 -0.01
Shares Outstanding 128.7 128.2 127.5 126.9 128.3 129.2 131.0 131.4 130.9 130.7 136.2 135.9 135.5 135.0 134.7 134.4 133.9 108.3 108.3 130.8 124.8 118.8 125.9 125.9 118.8
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q1
Current Assets
Cash & Cash Equivalents 65.7 90.9 93.3 75.5 95.3 98.7 162.3 177.9 168.8 167.3 163.6 131.5 129.5 296.6 341.5 349.9 362.5 364.6 376.8 159.8 168.6 165.2 (30.1)
Short-Term Investments 196.6 170.7 168.5 186.6 170.3 179.1 115.5 99.3 101.3 95.1 124.4 167.3 169.5 44.5 0 0 0 0 0 0 0 0 60.2
Net Receivables 56.5 72.1 61.7 56.7 55.2 60.6 52.6 44.8 50.4 56.1 57.6 52.1 45.1 50.9 40.0 37.2 32.0 29.6 30.8 25.5 15.5 18.1 0
Inventory 49.8 48.4 51.6 49.5 45.3 43.9 46.8 50.1 54.7 60.9 66.9 65.7 69.5 48.2 49.4 45.3 38.0 32.2 27.5 26.7 26.2 23.0 0
Other Current Assets 3.6 3.0 2.9 2.8 2.3 2.0 13.0 1.9 2.8 2.6 2.2 2.1 4.3 6.7 1.8 1.5 1.7 0.7 0.1 3.1 0.8 1.3 0
Total Current Assets 379.3 392.0 388.5 382.8 380.5 396.4 390.2 384.1 388.6 392.1 422.3 424.8 425.6 454.0 443.9 443.3 439.1 431.7 439.8 216.9 212.5 208.6 30.1
Non-Current Assets
Property, Plant & Equipment 31.1 29.3 29.2 34.7 27.7 28.1 28.6 27.4 28.2 29.3 29.1 28.0 28.7 27.6 22.3 21.0 20.3 5.9 5.0 3.9 2.5 2.1 0
Goodwill 16.7 16.7 16.7 16.7 16.7 16.7 16.2 16.2 16.2 16.2 16.5 19.1 19.1 10.1 10.1 10.1 10.1 10.1 0.5 0.5 0.5 0.5 0
Intangible Assets 15.7 16.8 17.7 18.6 19.4 20.1 20.5 21.4 22.3 23.1 24.3 23.7 24.7 4.3 4.5 3.9 4.3 4.7 0.4 0.3 0.3 0.3 0
Long-Term Investments 1.6 0 1.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 4.7 6.7 2.9 4.7 4.6 4.8 5.0 4.9 4.1 3.4 3.2 3.0 3.0 3.0 4.6 2.9 1.3 1.7 1.3 1.3 1.1 1.1 (30.1)
Total Non-Current Assets 69.8 69.5 106.4 110.5 102.1 103.1 101.0 99.6 103.4 102.4 97.1 100.2 99.0 65.5 55.4 49.5 46.8 31.6 14.5 13.3 11.7 11.4 (30.1)
Total Assets 449.1 461.5 494.9 493.3 482.6 499.5 491.2 483.7 492.1 494.5 519.4 525.1 524.6 519.5 499.3 492.8 485.9 463.3 454.3 230.3 224.3 220.0 0
Current Liabilities
Account Payables 6.7 6.4 7.6 6.9 6.2 5.5 5.4 3.2 3.7 3.0 4.7 3.1 5.3 4.8 5.6 6.7 6.0 3.0 3.9 3.3 3.4 2.9 0
Short-Term Debt 15.9 6.3 12.9 5.4 4.0 4.7 0 1.9 1.9 0.6 0.5 0.6 0.6 0.6 0 0 0 0 0 0 2.8 2.8 0
Deferred Revenue 30.0 29.6 28.7 30.0 28.7 26.6 25.4 25.0 24.7 24.1 24.7 22.1 21.3 14.5 13.1 10.0 13.4 8.1 6.4 4.7 3.5 4.3 0
Other Current Liabilities 16.4 18.1 11.3 16.1 12.7 16.9 32.0 13.1 14.8 16.7 16.8 15.3 14.2 17.3 13.1 15.3 9.0 12.0 14.4 13.2 11.4 12.0 0
Total Current Liabilities 80.9 77.8 75.2 73.3 67.7 67.7 62.8 52.4 55.6 56.2 58.7 53.6 56.5 49.0 41.5 42.4 42.8 33.2 30.0 28.2 27.8 26.5 0
Non-Current Liabilities
Long-Term Debt 7.0 0.5 8.8 0.8 0.9 1.1 1.2 1.3 1.5 1.6 1.7 1.9 2.1 2.3 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 2.4 9.1 2.5 11.0 11.2 11.4 19.2 18.7 18.5 18.9 18.4 18.5 17.9 17.2 16.6 16.0 15.8 14.9 13.4 206.8 205.9 206.0 0
Total Non-Current Liabilities 40.5 42.0 41.1 42.5 35.3 36.1 43.0 42.2 43.9 45.2 45.2 47.3 44.6 44.9 41.3 39.3 35.6 24.7 21.1 213.1 211.3 209.5 0
Total Liabilities 121.5 119.8 116.3 115.8 103.0 103.8 105.8 94.6 99.5 101.4 103.9 100.9 101.1 93.9 82.8 81.7 78.4 57.9 51.1 241.3 239.0 236.0 0
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0
Retained Earnings (120.6) (101.7) (57.7) (52.2) (46.6) (35.2) (44.8) (45.8) (35.3) (29.2) (34.7) (28.2) (23.8) (17.0) (20.6) (22.2) (21.6) (19.6) (18.4) (19.8) (22.5) (22.6) 0
Accumulated Other Comprehensive Income 2.4 2.2 0.8 (0.0) (0.6) 0.0 0.1 (0.2) (1.6) (1.3) (1.6) (1.8) (0.6) (0.7) (0.5) 0.2 0.9 0.9 0.6 0.5 0.3 0.1 (41.7)
Total Stockholders' Equity 327.6 341.7 378.6 377.6 379.6 395.7 385.5 389.1 392.6 393.1 415.5 424.2 423.5 425.3 416.4 411.0 407.2 405.0 402.9 (11.3) (15.1) (16.0) 33.0
Total Liabilities & Equity 449.1 461.5 494.9 493.3 482.6 499.5 491.2 483.7 492.1 494.5 519.4 525.1 524.6 519.5 499.3 492.8 485.9 463.3 454.3 230.3 224.3 220.0 33.0
Debt Metrics
Total Debt 36.3 23.7 35.2 23.7 15.9 17.0 9.0 13.8 14.4 14.1 15.3 16.2 17.3 18.1 15.7 14.8 14.9 0 0 0 2.8 2.8 0
Net Debt (29.3) (67.1) (58.1) (51.8) (79.4) (81.7) (153.3) (164.1) (154.4) (153.2) (148.3) (115.3) (112.2) (278.5) (325.8) (335.0) (347.6) (364.6) (376.8) (159.8) (165.8) (162.5) 30.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (18.9) (44.1) (5.5) (5.6) (11.4) 9.6 0.9 (10.4) (6.2) 5.5 (6.5) (4.4) (6.8) 3.7 1.7 (0.6) (2.2) (1.2) 0.3 0 0.1 5.6 6.5 8.1 (0.8)
Depreciation & Amortization 2.8 3.0 3.1 3.0 2.9 2.7 2.8 2.5 2.5 2.4 2.6 2.4 1.8 1.9 0.8 0.9 1.5 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.1
Stock-Based Compensation 4.9 5.5 5.6 6.8 6.6 7.0 7.1 7.2 5.6 5.7 5.8 5.9 4.7 4.5 4.4 0 3.8 3.0 0 0 0.5 0.3 0.1 0.1 0.1
Change in Working Capital 9.0 (3.5) (3.6) (0.8) 3.0 (5.5) (10.0) 8.1 1.8 (3.8) (5.3) (5.1) 3.4 (4.7) (16.0) (15.0) (5.2) 2.0 (3.4) (7.8) 0.6 4.7 (5.1) (8.6) 1.3
Other Non-Cash Items (0.4) (0.4) (0.9) (1.2) (0.9) (11.9) 12.4 (1.1) 0.2 (0.2) (0.8) (1.7) (0.3) 0.9 1.7 5.3 0.6 0.9 4.0 3.7 0.7 0.9 0.4 0.1 0.7
Operating Cash Flow (2.7) (0.8) (3.9) 0.1 (0.1) 2.0 13.2 6.2 4.0 9.5 (4.2) (2.9) 2.9 6.2 (7.5) (9.4) (1.5) 5.4 1.2 (3.9) 1.9 11.6 2.2 (0.1) 1.4
Investing Activities
Capital Expenditure (2.2) (1.0) (0.7) (1.6) (0.9) (0.9) (0.8) (1.2) (0.6) (1.6) (1.4) (1.4) (0.5) (6.6) (1.1) (1.3) (0.8) (1.3) (1.3) (1.3) (0.5) (0.2) (0.5) (0.5) (0.3)
Acquisitions 0 0 0 0 0 (0.5) (0.1) 0 0 (0.0) (0.0) 0 (44.9) 0 0 0 0 (17) 0.4 0 0.4 0 0 0 0
Purchases of Investments (95.6) (77.1) (59.6) (81.3) (60.2) (107.2) (52.8) (36.9) (77.1) (23.4) (23.5) (5.8) 0 (44.5) 0 (1.6) 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 70.7 76.1 79.2 66.5 70.4 45 38 40 72 54 68 10 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities (0.0) 0.2 0.0 (0.0) 0.0 0.2 (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (123.5) (0.1) (0.0) 0 0 0 (0.4) 0 0 0 0 0 0
Investing Cash Flow (27.1) (1.8) 18.9 (16.4) 9.5 (63.4) (15.8) 2.0 (5.8) 29.1 43.1 2.8 (168.9) (51.1) (1.1) (2.9) (0.8) (18.3) (1.3) (1.3) (0.1) (0.2) (0.5) (0.5) (0.3)
Financing Activities
Net Debt Issuance 4.2 (1.5) 1.9 1.2 (0.8) 2.6 (0.1) (0.1) 1.3 (0.1) (0.1) (0.1) (0.1) (0.1) 0 0 0 0 0 (2.8) 0 0 (1.3) 0 0
Stock Repurchased 0 0.0 0.0 (4.5) (10.6) (7.0) (11.9) (2.7) 0 (34.7) (8.4) 0 (0.1) 0 (0.1) 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.2) (0.3) (0.0) (0.1) (0.1) 0.7 0.0 1.1 0.4 1.1 0.3 0.4 0.2 2.7 0.2 0.7 0.4 0.0 0 0 0.2 119.7 0.1 4.1 0.0
Financing Cash Flow 4.0 (1.2) 1.9 (2.6) (11.5) (3.6) (12.1) (1.7) 1.6 (33.8) (8.3) 0.2 0 3.9 0.2 1.1 0.4 0.0 217.1 (3.7) 0.2 119.7 (1.2) 4.1 0.0
Cash Position
Net Change in Cash (25.2) (2.4) 17.8 (19.8) (3.4) (63.6) (15.6) 8.8 1.5 4.0 32.1 (0.8) (167.1) (42.0) (8.4) (12.6) (2.1) (12.2) 216.9 (8.7) 2.5 130.6 0.2 3.2 1.6
Cash at Beginning 90.9 93.3 75.5 95.3 98.7 162.3 177.9 169.1 167.6 163.6 131.5 132.4 299.5 341.5 349.9 362.5 364.6 376.8 159.8 168.6 166.1 35.5 35.3 32.1 30.5
Cash at End 65.7 90.9 93.3 75.5 95.3 98.7 162.3 177.9 169.1 167.6 163.6 131.5 132.4 299.5 341.5 349.9 362.5 364.6 376.8 159.8 168.6 166.1 35.5 35.3 32.1
Free Cash Flow (4.9) (1.8) (4.6) (1.5) (1.0) 1.1 12.4 5.0 3.3 8.0 (5.6) (4.2) 2.4 (0.4) (8.6) (10.8) (2.3) 4.2 (0.1) (5.2) 1.4 11.4 1.7 (0.6) 1.1
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 44.1 62.1 52.3 45.6 41.5 57.5 51.5 46.6 44.9 58.2 48 49.7 37.1 48.3 40.5 40.2 35.1 38.9 34.4 30.4 24.3 30.6 25.1 19.1 18.0
Gross Profit 21.3 32.9 27.6 23.9 20.2 33.7 29.0 25.4 23.0 33.0 27.2 28.2 21.0 29.4 26.9 24.6 20.2 23.6 21.3 19.7 14.5 19.4 15.6 8.3 8.4
Operating Income (18.5) (5.6) (9.2) (10.6) (15.0) 3.0 (4.2) (8.5) (10.7) (0.1) (6.4) (9.1) (12.2) 0.1 1.4 (0.9) (2.4) 1.3 2.9 3.8 1.1 7.9 6.7 (0.2) (0.7)
Net Income (18.9) (44.1) (5.5) (5.6) (11.4) 9.6 0.9 (10.4) (6.2) 5.5 (6.5) (4.4) (6.8) 3.5 1.7 (0.6) (2.0) (1.2) 1.4 2.7 0.1 5.6 6.5 8.1 (0.8)
EPS (Diluted) -0.15 -0.34 -0.04 -0.04 -0.09 0.07 0.01 -0.08 -0.05 0.04 -0.05 -0.03 -0.05 0.03 0.01 -0.00 -0.02 0.00 0.01 0.02 0.00 0.05 0.05 0.06 -0.01
Balance Sheet
Cash & Equivalents 65.7 90.9 93.3 75.5 95.3 98.7 162.3 177.9 168.8 167.3 163.6 131.5 129.5 296.6 341.5 349.9 362.5 364.6 376.8 159.8 168.6 165.2 (30.1)
Total Assets 449.1 461.5 494.9 493.3 482.6 499.5 491.2 483.7 492.1 494.5 519.4 525.1 524.6 519.5 499.3 492.8 485.9 463.3 454.3 230.3 224.3 220.0 0
Total Debt 36.3 23.7 35.2 23.7 15.9 17.0 9.0 13.8 14.4 14.1 15.3 16.2 17.3 18.1 15.7 14.8 14.9 0 0 0 2.8 2.8 0
Stockholders' Equity 327.6 341.7 378.6 377.6 379.6 395.7 385.5 389.1 392.6 393.1 415.5 424.2 423.5 425.3 416.4 411.0 407.2 405.0 402.9 (11.3) (15.1) (16.0) 33.0
Cash Flow
Operating Cash Flow (2.7) (0.8) (3.9) 0.1 (0.1) 2.0 13.2 6.2 4.0 9.5 (4.2) (2.9) 2.9 6.2 (7.5) (9.4) (1.5) 5.4 1.2 (3.9) 1.9 11.6 2.2 (0.1) 1.4
Capital Expenditure (2.2) (1.0) (0.7) (1.6) (0.9) (0.9) (0.8) (1.2) (0.6) (1.6) (1.4) (1.4) (0.5) (6.6) (1.1) (1.3) (0.8) (1.3) (1.3) (1.3) (0.5) (0.2) (0.5) (0.5) (0.3)
Free Cash Flow (4.9) (1.8) (4.6) (1.5) (1.0) 1.1 12.4 5.0 3.3 8.0 (5.6) (4.2) 2.4 (0.4) (8.6) (10.8) (2.3) 4.2 (0.1) (5.2) 1.4 11.4 1.7 (0.6) 1.1